OmniAb boosts 2026 cash outlook following Eli Lilly deal
The key point is the news that OmniAb has raised its cash outlook for 2026 based on its contract with Eli Lilly.
The current price of $3.38 is close to the 20-day high resistance level of $3.63, and due to the short-term surge, it is in an overbought phase with a significant gap from the support level of $1.90. Therefore, when considering a new entry, it is essential to carefully verify whether the resistance level will be broken or if it will settle at the support level.
Based on the current price of $3.38, if it reaches the 20-day high resistance level around $3.63, consider taking profits. If the risk of breaching the support level of $1.90 is managed during the short-term overbought phase, maintain the existing position, or respond with a stop-loss if the stop-loss level of $1.90 is breached.
The RSI(14) is at 90.4, indicating an extreme overbought condition, while the moving averages are in a non-aligned state. The trading volume is at 0.92 times the 20-day average, which is at an average level, and the volatility over the past 7 days has recorded +69.0%.
At the time of the forecast, a conservative approach was considered due to the extreme overbought condition indicated by an RSI of 90.4 and the price position nearing the 20-day high resistance level of $3.63. However, the actual result far exceeded the predicted return of 3.5%, achieving an actual return of 37.4% (OVERHIT). The strong positive news from the Eli Lilly contract completely overshadowed the burden of the short-term overheating indicators, leading to a strong upward trend.
Through this trading, it has been confirmed that when accompanied by strong tangible positive factors (such as large partnership contracts), the overbought signals from technical indicators can be temporarily ignored and lead to a larger upward trend. In future trading, even in short-term overheating periods, we will enhance our criteria to more flexibly assess and respond to the impact of major news that strengthens fundamentals.